Monovo (Mometasone Furoate)

Mometasone furoate, the active ingredient in Monovo, is a corticosteroid presented as a topical formulation for skin use. It is prescribed to reduce inflammation and itching associated with various dermatologic conditions such as atopic dermatitis, psoriasis and contact dermatitis, and is intended for adult and pediatric patients as directed by a healthcare professional.

GNH USA supplies Monovo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established logistics for regulated markets and ensuring compliance with local regulations through rigorous quality assurance processes.

Mometasone furoate is a topical corticosteroid used to manage inflammatory skin disorders.

Atopic dermatitis: reduces redness, swelling and itching, helping to control flare‑ups. Psoriasis: diminishes plaque formation and scaling, improving skin appearance. Contact dermatitis: alleviates irritation and inflammation caused by allergens or irritants.

Mometasone furoate may cause local and systemic adverse reactions.

Common Side Effects: - Burning or stinging at the application site. - Dryness or peeling of the skin. - Mild acne or folliculitis.

Serious or Rare Side Effects: - Skin thinning or atrophy with prolonged use. - Secondary bacterial, fungal or viral infection. - Systemic effects such as adrenal suppression or Cushingoid appearance.

When using topical mometasone furoate, consider the following precautions.

Assess severity: limit use to mild‑moderate disease and avoid prolonged continuous therapy. Avoid occlusion: do not cover treated area with airtight dressings unless directed. Pediatric use: apply only under medical supervision, using the lowest effective amount. Pregnancy & lactation: discuss risks with a healthcare provider before use. Monitor for infection: discontinue if signs of bacterial, fungal or viral infection appear. Store at ambient temperature: keep below 25 °C, in original container, protect from moisture and light.

Mometasone furoate may interact with other agents; monitor accordingly.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent systemic use may increase risk of systemic side effects. - CYP450 inducers (e.g., rifampicin): may reduce local efficacy.

Moderate Interactions (Monitor Closely): - Antifungal agents: may increase local irritation. - Antibiotic creams: monitor for additive skin irritation. - Immunosuppressants: may affect healing, monitor skin response.